Advertisement
ORIC Pharmaceuticals, Inc. (ORIC)
NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Follow
At close: 04:00PM EDT
After hours:
| Previous Close | 9.15 |
| Open | 9.21 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 9.18 - 9.47 |
| 52 Week Range | 5.34 - 16.65 |
| Volume | |
| Avg. Volume | 447,300 |
| Market Cap | 666.627M |
| Beta (5Y Monthly) | 1.11 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.76 |
| Earnings Date | Nov 04, 2024 - Nov 08, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 18.75 |
Simply Wall St.Companies Like ORIC Pharmaceuticals (NASDAQ:ORIC) Are In A Position To Invest In Growth
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
GlobeNewswireORIC® Pharmaceuticals Announces Presentation at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Oct. 09, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that the company will present a poster at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics to be held October 23-25, 2024, in Barcelona, Spain. Poster presentation details: Title:ORIC-114, a highly selective, brain penetr
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.